重组人含表皮生长因子样重复区和盘状结构域1的蛋白3(EDIL

特别提示：包括重组人含表皮生长因子样重复区和盘状结构域1的蛋白3(EDIL3)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人含表皮生长因子样重复区和盘状结构域1的蛋白3(EDIL3)
英文名称：Recombinant Human EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3
产品货号：JN0642
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Val17-Glu480在C端含有His标签。

EDIL3质量控制：＞95%(还原性SDS-PAGE)

EDIL3制剂：冻干品

EDIL3保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

EDIL3复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于EDIL3：
EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3 (EDIL3) is a 52 kDa extracellular matrix protein that is expressed by endothelial tissues during embryonic vascular development. EDIL3 becomes quiescent at the time of birth, and is no longer expressed in normal adult tissues. EDIL3 has been found to be re-expressed in a number of human tumors as well as in ischemic muscles and ischemic brain tissue, which may play an important role in adult angiogenesis. EDIL3 promotes adherence and migration of endothelial cells, and acts as an endothelial cell survival agent through upregulation of Bcl-2 expression. EDIL3 has also been shown to be an endogenous inhibitor of inflammatory cell recruitment by interfering with the integrin LFA-1-dependent leukocyte-endothelial adhesion. Human EDIL3 is synthesized as a precursor with a 16 amino acid signal sequence and a 464 amino acid mature chain.

我公司销售的重组人含表皮生长因子样重复区和盘状结构域1的蛋白3(EDIL3)，重组EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3，重组人EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3，Recombinant Human EGF-Like Repeat and Discoidin I-Like Domain-Containing Protein 3，重组含表皮生长因子样重复区和盘状结构域1的蛋白3，重组EDIL3，rEDIL3，重组人EDIL3，重组人含表皮生长因子样重复区和盘状结构域1的蛋白3，rhEDIL3质量上佳，价格普惠，欢迎广大新老客户踊跃订购。